Volume 22, Number 6—June 2016
Synopsis
Improved Global Capacity for Influenza Surveillance
Lauren S. Polansky
, Sajata Outin-Blenman, and Ann C. Moen
, Sajata Outin-Blenman, and Ann C. Moen
Table 6
Progress in national estimates and recommendations tied to availability of routine national influenza surveillance data for 35 countries participating in CDC influenza surveillance capacity strengthening, 2004–2013*
| Measures | Completed† |
In progress‡ | Not yet available | |
|---|---|---|---|---|
| Before | During | |||
| Seasonality | 10 | 19 | 4 | 2 |
| Burden of influenza disease among sentinel sites | 1 | 8 | 17 | 9 |
| Risk factors for influenza disease | 3 | 4 | 14 | 14 |
| Burden of influenza disease in population | 1 | 4 | 10 | 20 |
| Antiviral recommendations | 7 | 17 | 0 | 10 |
| Vaccine recommendations | 9 | 8 | 3 | 15 |
| Vaccine acceptability | 3 | 6 | 3 | 23 |
*A total of 39 countries partnered with CDC for influenza surveillance capacity strengthening during different years; 35 countries responded to a 2013 questionnaire and are included in our analysis. CDC, Centers for Disease Control and Prevention.
†Completed means that the measure was completed before or during the 10-year CDC capability-strengthening program.
‡In progress means that the measure was in progress during the 10-year program.
Page created: August 18, 2016
Page updated: August 18, 2016
Page reviewed: August 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.